169 related articles for article (PubMed ID: 29076965)
41. APOBEC-induced mutations in human cancers are strongly enriched on the lagging DNA strand during replication.
Seplyarskiy VB; Soldatov RA; Popadin KY; Antonarakis SE; Bazykin GA; Nikolaev SI
Genome Res; 2016 Feb; 26(2):174-82. PubMed ID: 26755635
[TBL] [Abstract][Full Text] [Related]
42. Epigenetic mechanisms might help explain environmental contributions to the pathogenesis of keratoconus.
McMonnies CW
Eye Contact Lens; 2014 Nov; 40(6):371-5. PubMed ID: 25320960
[TBL] [Abstract][Full Text] [Related]
43. Inherited factors and environmental exposures in cancer risk.
Shields PG
J Occup Med; 1993 Jan; 35(1):34-41. PubMed ID: 8423501
[TBL] [Abstract][Full Text] [Related]
44. Mutations and altered expression of the human cancer genes: what they tell us about causes.
Devereux TR; Risinger JI; Barrett JC
IARC Sci Publ; 1999; (146):19-42. PubMed ID: 10353382
[TBL] [Abstract][Full Text] [Related]
45. A Simple Model-Based Approach to Inferring and Visualizing Cancer Mutation Signatures.
Shiraishi Y; Tremmel G; Miyano S; Stephens M
PLoS Genet; 2015 Dec; 11(12):e1005657. PubMed ID: 26630308
[TBL] [Abstract][Full Text] [Related]
46. Genetic polymorphisms and micronucleus formation: a review of the literature.
Iarmarcovai G; Bonassi S; Botta A; Baan RA; Orsière T
Mutat Res; 2008; 658(3):215-33. PubMed ID: 18037339
[TBL] [Abstract][Full Text] [Related]
47. Mutational signatures and processes in hepatobiliary cancers.
Zhuravleva E; O'Rourke CJ; Andersen JB
Nat Rev Gastroenterol Hepatol; 2022 Jun; 19(6):367-382. PubMed ID: 35273358
[TBL] [Abstract][Full Text] [Related]
48. Cancer mutation signatures, DNA damage mechanisms, and potential clinical implications.
Harris RS
Genome Med; 2013; 5(9):87. PubMed ID: 24073723
[TBL] [Abstract][Full Text] [Related]
49. Discovering gene-environment interactions in glioblastoma through a comprehensive data integration bioinformatics method.
Kunkle B; Yoo C; Roy D
Neurotoxicology; 2013 Mar; 35():1-14. PubMed ID: 23261424
[TBL] [Abstract][Full Text] [Related]
50. Mutational spectra are associated with bacterial niche.
Ruis C; Weimann A; Tonkin-Hill G; Pandurangan AP; Matuszewska M; Murray GGR; Lévesque RC; Blundell TL; Floto RA; Parkhill J
Nat Commun; 2023 Nov; 14(1):7091. PubMed ID: 37925514
[TBL] [Abstract][Full Text] [Related]
51. p53 mutations in head and neck cancer: new data and evaluation of mutational spectra.
Olshan AF; Weissler MC; Pei H; Conway K
Cancer Epidemiol Biomarkers Prev; 1997 Jul; 6(7):499-504. PubMed ID: 9232336
[TBL] [Abstract][Full Text] [Related]
52. Lifestyle-related factors and environmental agents causing cancer: an overview.
Irigaray P; Newby JA; Clapp R; Hardell L; Howard V; Montagnier L; Epstein S; Belpomme D
Biomed Pharmacother; 2007 Dec; 61(10):640-58. PubMed ID: 18055160
[TBL] [Abstract][Full Text] [Related]
53. Mutational Strand Asymmetries in Cancer Genomes Reveal Mechanisms of DNA Damage and Repair.
Haradhvala NJ; Polak P; Stojanov P; Covington KR; Shinbrot E; Hess JM; Rheinbay E; Kim J; Maruvka YE; Braunstein LZ; Kamburov A; Hanawalt PC; Wheeler DA; Koren A; Lawrence MS; Getz G
Cell; 2016 Jan; 164(3):538-49. PubMed ID: 26806129
[TBL] [Abstract][Full Text] [Related]
54. Genotoxicity of 1,3-butadiene and its epoxy intermediates.
Walker VE; Walker DM; Meng Q; McDonald JD; Scott BR; Seilkop SK; Claffey DJ; Upton PB; Powley MW; Swenberg JA; Henderson RF;
Res Rep Health Eff Inst; 2009 Aug; (144):3-79. PubMed ID: 20017413
[TBL] [Abstract][Full Text] [Related]
55. Experimental Delineation of Mutational Signatures Is an Essential Tool in Cancer Epidemiology and Prevention.
Zavadil J; Rozen SG
Chem Res Toxicol; 2019 Nov; 32(11):2153-2155. PubMed ID: 31509385
[TBL] [Abstract][Full Text] [Related]
56. Identification of multiplicatively acting modulatory mutational signatures in cancer.
Kičiatovas D; Guo Q; Kailas M; Pesonen H; Corander J; Kaski S; Pitkänen E; Mustonen V
BMC Bioinformatics; 2022 Dec; 23(1):522. PubMed ID: 36474143
[TBL] [Abstract][Full Text] [Related]
57. [DNA methylation analysis in environmental and occupational cancer research].
Baccarelli A; Marinelli B; Bollati V; Albetti B; Consonni D; Bonzini M; Pesatori AC; Bertazzi PA
G Ital Med Lav Ergon; 2005; 27(3):267-71. PubMed ID: 16240570
[TBL] [Abstract][Full Text] [Related]
58. Identification of coding and non-coding mutational hotspots in cancer genomes.
Piraino SW; Furney SJ
BMC Genomics; 2017 Jan; 18(1):17. PubMed ID: 28056774
[TBL] [Abstract][Full Text] [Related]
59. [Epigenetics of schizophrenia: a review].
Rivollier F; Lotersztajn L; Chaumette B; Krebs MO; Kebir O
Encephale; 2014 Oct; 40(5):380-6. PubMed ID: 25127897
[TBL] [Abstract][Full Text] [Related]
60. Gene-environment interactions in heavy metal and pesticide carcinogenesis.
Tabrez S; Priyadarshini M; Priyamvada S; Khan MS; Na A; Zaidi SK
Mutat Res Genet Toxicol Environ Mutagen; 2014 Jan; 760():1-9. PubMed ID: 24309507
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
